Aviva’s Inspire Medical Systems INSP Stock Holding History

Aviva’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$460K	Buy	10,306 +2,846	+38%	+$135K	﹤0.01%	743
2026 Q1	$385K	Buy	+7,460	New	+$522K	﹤0.01%	809
2025 Q3	–	Sell	-3,396	Closed	-$441K	–	897
2025 Q2	$441K	Sell	3,396 -35	-1%	-$5.08K	﹤0.01%	834
2025 Q1	$546K	Buy	+3,431	New	+$621K	﹤0.01%	781
2021 Q2	–	Sell	-6,153	Closed	-$1.27M	–	918
2021 Q1	$1.27M	Sell	6,153 -3,687	-37%	-$784K	0.01%	759
2020 Q4	$1.85M	Sell	9,840 -7,976	-45%	-$1.3M	0.01%	689
2020 Q3	$2.3M	Sell	17,816 -9,169	-34%	-$1.01M	0.01%	689
2020 Q2	$2.35M	Sell	26,985 -36,078	-57%	-$2.77M	0.01%	616
2020 Q1	$3.8M	Buy	63,063 +34,105	+118%	+$2.52M	0.03%	491
2019 Q4	$2.15M	Buy	+28,958	New	+$1.86M	0.01%	660

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Aviva's INSP Position: Q2 2026 in Review

Aviva increased its Inspire Medical Systems (INSP) stake by 38% in Q2 2026, buying an estimated $135K and bringing the position to 10,306 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #743.

Aviva first reported a position in INSP in Q4 2019 and has held it in 10 quarters since. The position peaked at $3.8M in Q1 2020. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

Aviva held 10,306 shares of Inspire Medical Systems worth $460K as of Q2 2026.
Aviva bought 2,846 Inspire Medical Systems shares in Q2 2026, an estimated $135K.
Inspire Medical Systems made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #743 holding.
Aviva first reported a position in Inspire Medical Systems in Q4 2019 and has held it in 10 quarters since.
Aviva's Inspire Medical Systems position peaked at $3.8M in Q1 2020.
276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.